Posts in category Business Standard
National Stock Exchange aims for extended F&O trading hours by March 2024 (25-09-2023)
The extension is dependent on the approval of the markets regulator, for which the exchange filed the proposal weeks earlier
Brokerages recommend JSW Infra IPO, cite firm’s govt contracts among risks (25-09-2023)
Sajjan Jindal company is the third listing by the JSW Group and it comes after a gap of 13 years
Rockingdeals Circular Economy files IPO papers to further brand positioning (25-09-2023)
B2B re-commerce player Rockingdeals Circular Economy Ltd (RDCEL) on Monday said it has filed draft papers to raise funds through an Initial Public Offering (IPO).
The shares of the company will be listed on the NSE Emerge, the company said in a statement.
The IPO comprises a fresh issue of equity shares of up to 15 lakh equity shares with a face value Rs 10 each through the book-building process.
Proceeds from the issue will be utilised towards working capital requirement, brand positioning, marketing, advertising, and general corporate purpose, the company said.
The company recently concluded its pre-IPO round comprising a preferential issue of 4,80,130 shares at an issue price of Rs 100 apiece, it said.
"We are delighted to reach yet another milestone and get closer to our mission of becoming a publicly listed company," RDCEL Promoter and Managing Director Aman Preet said.
Corporate Capital Ventures Pvt Ltd is the book-running lead manager of the IPO.
RDCEL is a B2B sourcing .
Emcure Pharma plans $400-500 mn IPO in 2024; hires JP Morgan, Jefferies (25-09-2023)
Emcure, backed by private equity firm Bain Capital, has hired investment banks JP Morgan, Jefferies and Kotak for the IPO, and is targeting a valuation of about $3 billion
Sugar shares in focus; Balrampur, Dwarikesh, Dhampur, Dalmia rally up to 8% (25-09-2023)
Dalmia Bharat said the outlook for the FY2023-24 seems stable as there will be less pressure on stock levels and the company can expect improved profitability and realizations
Pricey valuations threaten best Indian media stocks rally in 14 years (25-09-2023)
Optimists are focusing on the upcoming pipeline of movies, two of which feature India's biggest superstars, and a potential boost to advertisement spending
Strides Pharma soars 8% on USFDA nod for drug to treat heart diseases (25-09-2023)
Meanwhile, Strides said the board is scheduled to meet on September 25, to consider the combine CDMO interests of the group to become one of India's top specialty pharmaceuticals CDMOs
Strides Pharma soars 8% on USFDA nod for drug to treat heart diseases (25-09-2023)
Meanwhile, Strides said the board is scheduled to meet on September 25, to consider the combine CDMO interests of the group to become one of India's top specialty pharmaceuticals CDMOs
Nomura retains negative view on rupee despite JPMorgan index inclusion (25-09-2023)
Actual inflows may be smaller with some real money managers that they tracked already invested about 2%-3% on average, the brokerage said
Nomura retains negative view on rupee despite JPMorgan index inclusion (25-09-2023)
Actual inflows may be smaller with some real money managers that they tracked already invested about 2%-3% on average, the brokerage said